Duke-led Center Seeks to Examine and Engineer the Microbial Communities of Indoor Spaces
New $26 million center will work to understand and engineer the microbiomes in our homes, workspaces and other built environments
Students research shines with help from pilot grants
The Duke School of Medicine Precision Genomics Collaboratory and the Office of Biomedical and Graduate Education have been providing $2,000 pilot grant opportunities three times a year for current biomedical PhD students since August 2021.
After receiving their grants, students have six months to use their funds, which could go towards research or professional development.
Jumping genes drive drug resistance of a world-wide fungal pathogen
Drug-resistant microbial pathogens — whether parasite, bacteria, virus, or fungus — are a major global challenge that can lead to limited treatment options, increased costs for resources, and higher levels of morbidity and mortality.
A Duke-led international research team has discovered one of the ways that drug resistance can develop: a process by which mobile DNA sequences called transposons trigger “hypermutation,” allowing certain genetic components to multiply unchecked.
Summer Scholars leave Duke with a once-in-a-lifetime research experience
This summer, eight scholars from across the country were paired with a faculty research mentor to learn laboratory skills, designing a research project, and effectively presenting future research.
It Doesn't Matter Much Which Fiber You Choose -- Just Get More Fiber
The human gut evolved to thrive on fermentable fibers, not bacon cheeseburgers
CRISPR Technology Demonstrates Success in Preventing and Treating COVID
In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.
Q&A with Charis Eng
Charis Eng, MD, PhD, FACP, is a leader in the field of cancer genetics. She was the first to discover a link between mutations in the cancer suppressor gene PTEN and Cowden syndrome and other disorders that can put patients at an increased risk for several types of cancer.
Two PGC Faculty Among 2022 DST Spark Seed Grant Winners
The Office for Research and Innovation has awarded funding to nine best-in-class projects, including two faculty from the Precision Genomics Collaboratory, for the inaugural Duke Science and Technology (DST) Spark Seed Grant program. This year’s winners include early- to mid-career faculty from across campus and the School of Medicine who were selected from a pool of 52 finalists for delivering innovative and creative ideas in pursuit of new directions and the enhancement of research and scholarship at Duke.
